Literature DB >> 87792

Recurrent anaphylaxis due to Plasmodium vivax infection.

B K Sharma, K K Talwar, V Bhatnagar, L Kumar, N K Ganguly, R C Mahajan.   

Abstract

Entities:  

Mesh：

Year:  1979        PMID： 87792     DOI： 10.1016/s0140-6736(79)91965-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Presentation of Plasmodium vivax malaria.

Authors:  A Jabbar; S M Shah
Journal:  Postgrad Med J       Date:  1997-09       Impact factor: 2.401

2.  Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes.

Authors:  H Hisaeda; A W Stowers; T Tsuboi; W E Collins; J S Sattabongkot; N Suwanabun; M Torii; D C Kaslow
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

3.  Delayed-type hypersensitivity and immunoglobulin E in American cutaneous leishmaniasis.

Authors:  N R Lynch; L Yarzábal; O Verde; J L Avila; H Monzon; J Convit
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.